Allarity Therapeutics, Inc. — Form D
Allarity Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-02. The offering totals $1.4M, of which $400K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-02
- Form: D
- Accession: 0001213900-24-009722
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $400K
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2024-01-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-504322
Issuer
- Name: Allarity Therapeutics, Inc.
- CIK: 0001860657
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 24 SCHOOL ST., 2ND FLOOR, BOSTON, MA, 02108
- Phone: 401-426-4664
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Laura Benjamin | Director | Boston, MA |
| Thomas Jensen | Director | Boston, MA |
| Gerald McLaughlin | Director | Boston, MA |
| Joseph Vazzano | Director | Boston, MA |
| Joan Brown | Executive Officer | Boston, MA |
| Thomas Jensen | Executive Officer | Boston, MA |
| David A Roth | Director | Denver, CO |
| James Cullem | Director | Boston, MA |
| James Cullem | Executive Officer | Boston, MA |
| Gerald G McLaughlin | Director | Boston, MA |
| Steen A Knudsen | Executive Officer | Boston, MA |
| Thomas A Jensen | Director | Boston, MA |
| Thomas A Jensen | Executive Officer | Boston, MA |
| Marie A Foegh | Executive Officer | Boston, MA |
| Joan G Brown | Executive Officer | Boston, MA |
| James G Cullem | Director | Boston, MA |
| James G Cullem | Executive Officer | Boston, MA |
| Steve Carchedi | Director | Cambridge, MA |
| Steve Carchedi | Executive Officer | Cambridge, MA |
| Jens Erik Knudsen | Executive Officer | Cambridge, MA |
Other filings by this issuer (5)
More